Adjuvant Everolimus Appears Beneficial in Very High-Risk Kidney Cancer

Adjuvant everolimus improves recurrence-free survival in patients with fully resected renal cell carcinoma who have a very high risk of disease recurrence.

Related Keywords

Oregon , United States , Christopherw Ryan , , Oregon Health Science University In Portland , Oregon Health , Science University ,